$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Trans-Cinnamaldehyde가 Lipopolysaccharide로 처리된 BV-2 cell에 미치는 항염증 기전 연구: Microarray 분석

The Effect of Trans-cinnamaldehyde on the Gene Expression of Lipopolysaccharide-stimulated BV-2 Cells Using Microarray Analysis

大韓韓醫學會誌 = Journal of Korean Oriental Medicine, v.30 no.4, 2009년, pp.13 - 27  

선영재 (경희대학교 대학원 한방응용의학과) ,  최영곤 (경희대학교 대학원 한방응용의학과) ,  정미영 (경희대학교 대학원 한방응용의학과) ,  황세희 (경희대학교 대학원 한방응용의학과) ,  이제현 (동국대학교 한의과대학 본초학교실) ,  조정희 (전라남도한방산업진흥원) ,  임사비나 (경희대학교 대학원 한방응용의학과)

Abstract AI-Helper 아이콘AI-Helper

Objectives: Trans-cinnamaldehyde (TCA) is the main component of Cinnamomi Ramulus and it has been reported that TCA inhibits inflammatory responses in various cell types. Inflammation-mediated neurological disorders induce the activation of macrophages such as microglia in brain, and these activated...

주제어

참고문헌 (39)

  1. KFDA (Korea Food & Drug Administration). The Korean Herbal Phamacopoeia. 8th ed. Seoul: Yakup Daily. 2002:1241-1243. 

  2. Park HJ, Lee JS, Lee JD, Kim NJ, Pyo JH, Kang JM, et al.. The anti-inflammatory effect of Cinnamomi Ramulus. J Korean Oriental Med. 2005; 26(2):140-151. 

  3. Lee HS, Kim BS, Kim MK. Suppression effect of Cinnamomum cassia derived component on nitric oxide synthase. J Agric Food Chem 2002; 50:7700-7703. 

  4. Guo JY, Huo HR, Zhao BS, Liu HB, Li LF, Ma YY, et al.. Cinnamaldehyde reduces IL-1betainduced cyclooxygenase-2 activity in rat cerebral 

  5. Chao LK, Hua KF, Hsu HY, Cheng SS, Lin IF, Chen CJ, et al.. Cinnamaldehyde inhibits proinflammatory cytokines secretion from monocytes/macrophages through suppression of intracellular signaling. Food Chem Toxicol. 2008; 46 (1):220-231. 

  6. Lundberg IE. The role of cytokines, chemokines and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies. Current Rheumatology Report. 2000;2:216-224. 

  7. Murabe Y, Sano Y. Morphological studies on neuralgia.. Postnatal development of microglia cells. Cell Tissue Res. 1982; 225: 469-485. 

  8. Gonzalez-Scarano F, Baultuch G. Microglia as mediators of inflammatory and degenerative disease. Annual Rev Neurosci. 1999;34:307-321. 

  9. Orr CF, Rowe DB, Haliday GM. An inflammatory review of Parkinson’s disease. Progress in Neurobiology. 2002;68:325-340. 

  10. Norton WT, Aquino DA, Hozymi I, Chiu FC, Brosnan CF. Quantitive aspects of reactive gliosis: a review. Neurochem. Res. 1992;17:877-885. 

  11. GeneChip Whole Transcript (WT) Sense Target Labeling Assay Manual Version 4; Copyright 2007, Affymetrix, Inc. 

  12. Kim DH, Kim CH, Kim MS, Kim JY, Jung KJ, Chung JH, et al.. Suppression of age-related inflammatory NF- $\kappa$ B activation by cinnamaldehyde. Biogerontology 2007;8:545-554. 

  13. Meme W, Calvo CF, Froger N, Ezan P, Amigou E, Koulakoff A, et al.. Proinflammatory cytokines released from microglia inhibit gap junctions in 

  14. Lue LF, Rydel R, Brigham EF, Yang LB, Hampel H, Murphy GM Jr, et al.. Infalmmatory repertoire of Alzheimer’s disease and nondemented elderly microglia in vitro. Glia. 2001; 35: 72-79. 

  15. Moilanen E, Whittle B, Moncada S. Nitric oxide as a factor in inflammation. In: Gallin JI, Snyderman R, Editors, Inflammation: basic principles and clinical corralates. Williams and Wilkins, Philadelphia. 1999;787-800. 

  16. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43:109-142. 

  17. Campbell A. Inflammation, neurodegenerative diseases, and environmental exposures. Ann. N.Y. Acad. Sci. 2004;1035:117-132. 

  18. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cellular Signaling. 2001;13:85-94. 

  19. Stuechr DJ. Structure-function aspects in the nitric oxide synthases. Annu. Rev. Pharmacol. Toxicol. 1997;37:339-359. 

  20. Meda L, Cassatella MA, Szendrei GI, Otvos L, Baron P, Villalba M, et al.. Activation of micr-oglial cell by $\beta$ -amyloid protein and interferon- $\gamma$ . Nature. 1995;374:647-650. 

  21. Miyasaka N, Hirata Y. Nitric oxide and inflammatory arthritides. Life Sci. 1997;61(21):2073-2081. 

  22. Lucas SM, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. British Journal of Pharmacology. 2006;147:232-240. 

  23. Sedgwick JD, Riminton DS, Cyster JG, Korner H. Tumor necrosis factor: a master-regulator leukocyte movement. Immunol Today. 2000;21:110-113. 

  24. Hoozemans JJ, Veerhuis R, Janssen I, van Elk EJ, Rozemuller AJ, Eikelenboom P. The role of cyclo-oxygenase 1 and 2 activity in prostaglandin E (2) secretion by cultured human adult microglia : implications for Alzheimer’s disease. Brain Res. 2002;951:218-226. 

  25. Teismann P, Tieu K, Choi DK, Wu DC, Naini A, Hunot S, et al.. Cyclooxygenase-2 is instrumental in Parkinson’s disease neurodegeneration. Proc Natl Acad Sci USA. 2003;100(9):5473-5478. 

  26. Leib SL, Leppert D, Clements J, Tauber MG. Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infect Immun. 2000;68:615-620. 

  27. Kieseier BC, Schneider C, Clements JM, Gearing AJ, Gold R, Toyka KV, et al.. Expression of specific matrix metalloproteinases in inflammatory myopathies. Brain. 2001;124:341-351. 

  28. Jiang Z, Johnson HJ, Nie H, Qin J, Bird TA, Li X. Pellino 1 is required for interleukin-1 (IL-1) -mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor- associated factor 6 (TRAF6) complex. J Biol Chem. 2003; 278(13):10952-10956. 

  29. Lyons RM, Moses HL. Transforming growth factors and the regulation of cell proliferation. Eur J Biochem. 1990;187:461-473. 

  30. Howe HL, Wingo PA, Thun MJ, Ries LA, Rosenberg HM, Feigal EG, et al.. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst. 2001;93:824-842. 

  31. Massari ME, Murre C. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol. 2000;20:429-440. 

  32. Norton JD. ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci. 2000;113:3897-3905. 

  33. Springhorn JP, Singh K, Kelly RA, Smith TW. Posttranscriptional regulation of Id1 activity in cardiac muscle. Alternative splicing of novel Id1 transcript permits homodimerization. J Biol Chem. 1994;269:5132-5136. 

  34. Martin M, Lefaix J, Delanian S. TGF- $\beta$ 1 and radiation fibrosis : a master switch and a specific therapeutic target. International Journal of Radiation Oncology, Bio and Physics. 2000;47(2):277-290. 

  35. Yue J, Mulder KM. Transforming growth factor- $\beta$ signal transduction in epithelial cells. Pharmacology & Therapeutics. 2001;91:1-34. 

  36. Kowanetz M, Valcourt U, Bergstrom R, Heldin CH, Moustakas A. Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein. Mol Cell Biol. 2004;24(10):4241-4254. 

  37. Kim WK, Hwang SY, Oh ES, Piao HZ, Kim KW, Han IO. TGF-beta1 represses activation and resultant death of microglia via inhibition of phosphatidylinositol 3-kinase activity. J Immunol. 2004;172:7015-7023. 

  38. Wyss-Coray T. TGF-Beta pathway as a potential target in neurodegeneration and Alzheimer’s. Curr Alzheimer Res. 2006;3(3):191-195. 

  39. Kleinert H, Euchenholer C, Ihrig-Biedert I, Forstermann U. Glucocorticoids inhibit the induction of nitric oxide synthase II by downregulating cytokine -induced activity of transcription factor nuclear factor- $\kappa$ B. Mol Pharmacol. 1996;49:15-21. 

저자의 다른 논문 :

LOADING...

관련 콘텐츠

이 보고서와 함께 이용한 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트